NF2 wild-type meningiomas are also enriched for ‘driver mutations’ in members of the PI3K-AKT-mTOR pathway, most commonly PIK3CA, AKT1, and to a lesser extent PIK3R1 (7, 39–41). This evidence concerns the gene MTOR and meningioma.